CUTR Stock Overview Provides aesthetic and dermatology solutions for medical practitioners worldwide. More details
Rewards Risk Analysis + 1 more risk
See All Risk Checks Capture your thoughts, links and company narrative
Price History & Performance
Summary of share price highs, lows and changes for Cutera Historical stock prices Current Share Price US$0.36 52 Week High US$4.97 52 Week Low US$0.28 Beta 1.28 1 Month Change 14.88% 3 Month Change -48.07% 1 Year Change -88.00% 3 Year Change -99.07% 5 Year Change -99.00% Change since IPO -97.40%
Recent News & Updates
Cutera Receives Deficiency Notice from Nasdaq Regarding Minimum $15 Million Market Value of Publicly Held Shares Requirement under Nasdaq Marketplace Rule 5450(b)(3)(C) Nov 23
Consensus EPS estimates fall by 16% Nov 14
Third quarter 2024 earnings: EPS misses analyst expectations Nov 10
New major risk - Market cap size Nov 10
Cutera, Inc. Reaffirms Financial Guidance for the Full Year 2024 Nov 09
Cutera, Inc. to Report Q3, 2024 Results on Nov 07, 2024 Oct 08 See more updates
Cutera Receives Deficiency Notice from Nasdaq Regarding Minimum $15 Million Market Value of Publicly Held Shares Requirement under Nasdaq Marketplace Rule 5450(b)(3)(C) Nov 23
Consensus EPS estimates fall by 16% Nov 14
Third quarter 2024 earnings: EPS misses analyst expectations Nov 10
New major risk - Market cap size Nov 10
Cutera, Inc. Reaffirms Financial Guidance for the Full Year 2024 Nov 09
Cutera, Inc. to Report Q3, 2024 Results on Nov 07, 2024 Oct 08
Cutera Receives Deficiency Notice from Nasdaq Regarding Listing Rule 5450(a)(1) Oct 02
Cutera, Inc. (NASDAQ:CUTR) Looks Inexpensive After Falling 47% But Perhaps Not Attractive Enough Aug 20
Second quarter 2024 earnings: EPS and revenues miss analyst expectations Aug 09
Cutera, Inc. Revises Revenue Guidance for the Year 2024 Aug 09
High number of new and inexperienced directors Aug 01
Cutera, Inc. to Report Q2, 2024 Results on Aug 08, 2024 Jul 26 Cutera, Inc.(NasdaqGS:CUTR) dropped from Russell 3000 Index
Revenues Working Against Cutera, Inc.'s (NASDAQ:CUTR) Share Price Following 28% Dive Jun 22
Price target decreased by 17% to US$6.33 Jun 18
High number of new and inexperienced directors Jun 18 Cutera, Inc., Annual General Meeting, Jul 15, 2024
Cutera, Inc. Reiterates Earnings Guidance for 2024 May 10
Cutera, Inc. to Report Q1, 2024 Results on May 09, 2024 Apr 28
Cutera, Inc. Announces North America Launch of xeo+ Apr 12
Cutera, Inc. Provides Revenue Guidance for the Full Year 2024 Mar 22 Cutera, Inc. announced delayed annual 10-K filing Mar 19
Revenues Working Against Cutera, Inc.'s (NASDAQ:CUTR) Share Price Following 35% Dive Mar 14
Consensus EPS estimates fall by 33% Mar 12
Third quarter 2023 earnings: EPS and revenues miss analyst expectations Mar 06
Cutera, Inc. to Report Q4, 2023 Results on Mar 21, 2024 Mar 02
Price target decreased by 59% to US$7.67 Feb 13
High number of new and inexperienced directors Feb 13 Cutera, Inc. Revises Revenue Guidance for the Full Year 2023 Jan 10
Cutera, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Annual Report on Form 10-Q Nov 17
Cutera, Inc. announced delayed 10-Q filing Cutera, Inc. Announces Resignation of Juliane Park from the Board of Directors, Effective as of December 1, 2023
Cutera, Inc. to Report Q3, 2023 Results on Nov 08, 2023 Oct 26
Janet Widmann Resigns from the Board of Directors of Cutera, Inc. Effective November 1, 2023 Oct 07
New minor risk - Market cap size Oct 05
Cutera, Inc. Appoints Brent Hauser as President, International Oct 05
Cutera, Inc. Announces the Launch of New Skin Resurfacing and Revitalization Platform Secret DUO Sep 08
President recently bought US$297k worth of stock Aug 31
Cutera, Inc. Appoints Jeffrey Jones as Chief Operating Officer, Effective August 28, 2023 Aug 25
Consensus revenue estimates fall by 14% Aug 16
Analysts Are More Bearish On Cutera, Inc. (NASDAQ:CUTR) Than They Used To Be Aug 11
New major risk - Share price stability Aug 10
Second quarter 2023 earnings: EPS and revenues miss analyst expectations Aug 09
Price target decreased by 8.9% to US$23.00 Aug 09
Cutera, Inc. Provides Revenue Guidance for the Full Year 2023 Aug 09
Cutera, Inc. Appoints Talyor C. Harris as President, Effective August 7, 2023 Aug 02
Cutera, Inc. Announces CEO Changes, Effective August 7, 2023 Jul 28
Cutera, Inc. to Report Q2, 2023 Results on Aug 08, 2023 Jul 24
the Gross Law Firm Notifies Shareholders of Cutera, Inc. of A Class Action Lawsuit and A Lead Plaintiff Deadline of July 24, 2023 Jun 29
Cutera, Inc. Announces A New U.S. Food and Drug Administration Clearance of AviClear as A Long-Term Treatment for Mild to Severe Inflammatory Acne Vulgaris Jun 16
Cutera, Inc. Announces Resignation of J. Daniel Plants as Director Jun 12
Independent Director notifies of intention to sell stock Jun 10
Cutera, Inc. Announces Resignation of Joseph E. Whitters from the Board of Directors Jun 08
Kessler Topaz Meltzer & Check, LLP Files a Securities Fraud Class Action Lawsuit Against Cutera, Inc May 25
Less than half of directors are independent May 24
Cutera, Inc. Announces Board Changes May 20
Cutera, Inc. Appoints Stuart Drummond as Interim Chief Financial Officer May 18
Voce Capital and David Mowry Terminate Proxy Solicitation May 16
Cutera, Inc. Announces Chief Financial Officer Changes May 11
First quarter 2023 earnings: EPS and revenues miss analyst expectations May 10
An Intrinsic Calculation For Cutera, Inc. (NASDAQ:CUTR) Suggests It's 48% Undervalued Apr 19
Full year 2022 earnings: EPS misses analyst expectations Apr 09
Consensus EPS estimates fall by 57% Mar 07
Now 21% undervalued after recent price drop Mar 02
Full year 2022 earnings: EPS misses analyst expectations Mar 01
Does Cutera (NASDAQ:CUTR) Have A Healthy Balance Sheet? Jan 11
Price target decreased to US$61.20 Jan 11 Cutera, Inc. to Report Q4, 2022 Results on Feb 28, 2023
Cutera, Inc. Announces AviClear™ Now Broadly Available to US Physicians and Practitioners Upon National Launch Nov 08
Third quarter 2022 earnings released: US$0.62 loss per share (vs US$0.077 loss in 3Q 2021) Nov 04
Cutera, Inc. Reiterates Revenue Guidance for the Full Year of 2022 Nov 04
Cutera, Inc. Announces Committee Appointments Nov 03
Cutera, Inc. to Report Q3, 2022 Results on Nov 03, 2022 Oct 21
Would Cutera (NASDAQ:CUTR) Be Better Off With Less Debt? Oct 06
Cutera, Inc. Announces Resignation of Katherine S. Zanotti from the Board Sep 27
Cutera: Shares Very Attractively Priced, Top-Line Hedged From CMS Sep 08
Cutera, Inc. (NASDAQ:CUTR) Shares Could Be 49% Below Their Intrinsic Value Estimate Sep 01
Cutera, Inc. Reiterates Revenue Guidance for the Full Year of 2022 Aug 06
Second quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind Aug 05
Cutera, Inc. to Report Q2, 2022 Results on Aug 04, 2022 Jul 29
Cutera, Inc. Announces AviClear Secured Clearance from Health Canada Jul 14
Cutera: The 'AviClear' Sign To Get Bullish Jun 22
Cutera (NASDAQ:CUTR) Is Carrying A Fair Bit Of Debt May 27
Cutera, Inc. Reiterates Revenue Guidance for the Full Year of 2022 May 12
First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind May 11
Consensus forecasts updated May 07
Cutera, Inc., Annual General Meeting, Jun 15, 2022 May 03
Price target increased to US$69.60 Apr 27 Shareholder Returns CUTR US Medical Equipment US Market 7D 1.3% -1.5% -2.4% 1Y -88.0% 10.0% 23.4%
See full shareholder returns
Return vs Market: CUTR underperformed the US Market which returned 23.4% over the past year.
Price Volatility Is CUTR's price volatile compared to industry and market? CUTR volatility CUTR Average Weekly Movement 14.6% Medical Equipment Industry Average Movement 7.6% Market Average Movement 6.3% 10% most volatile stocks in US Market 16.8% 10% least volatile stocks in US Market 3.1%
Stable Share Price: CUTR's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: CUTR's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company Cutera, Inc. provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform.
Show more Cutera, Inc. Fundamentals Summary How do Cutera's earnings and revenue compare to its market cap? CUTR fundamental statistics Market cap US$7.34m Earnings (TTM ) -US$143.71m Revenue (TTM ) US$155.21m
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) CUTR income statement (TTM ) Revenue US$155.21m Cost of Revenue US$146.01m Gross Profit US$9.20m Other Expenses US$152.91m Earnings -US$143.71m
Last Reported Earnings
Sep 30, 2024
Earnings per share (EPS) -7.12 Gross Margin 5.93% Net Profit Margin -92.59% Debt/Equity Ratio -166.3%
How did CUTR perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/12/22 06:21 End of Day Share Price 2024/12/20 00:00 Earnings 2024/09/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Cutera, Inc. is covered by 11 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Anup Mehta Canaccord Genuity Louise Chen Cantor Fitzgerald & Co. Jennie Tsai G. Research, LLC
Show 8 more analysts 
